ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
Journal of Chromatography A
Volume 1114, Issue 2, 12 May 2006, Pages 224-233
ExTech 2005 - 7th International Symposium on Advances in Extraction Technologies
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (346 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
Special issue
View Record in Scopus
 
doi:10.1016/j.chroma.2006.02.038    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier B.V. All rights reserved.

Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography–tandem mass spectrometry analysis in hospital effluent wastewatersstar, open

M. José Gómeza, Corresponding Author Contact Information, E-mail The Corresponding Author, Mira Petrovićb, c, Amadeo R. Fernández-Albaa and Damià Barcelób

aDepartment of Analytical Chemistry, University of Almería, 04120 Almería, Spain bDepartment of Environmental Chemistry IIQAB-CSIC, c/Jordi, Girona 18-26, 08034 Barcelona, Spain cICREA – Catalan Institution for Research and Advanced Studies, Passeig Lluis Companys 23, 08010 Barcelona, Spain

Received 28 July 2005; 
revised 5 February 2006; 
accepted 8 February 2006. 
Available online 20 March 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

A multi-residue analytical method has been developed and validated for determining a selection of 16 pharmaceuticals: the anti-epileptic carbamazepine, seven analgesic/anti-inflammatory drugs (mefenamic acid, indomethacine, ibuprofen, naproxen, diclofenac, ketorolac and acetaminophen), the analgesic opiate codeine, two antidepressants (fluoxetine and paroxetine), β-blockers (atenolol and propranolol), antibiotic (trimethoprim, metronidazole, and erythromycin) and the anti-ulcer ranitidine in hospital effluent wastewaters. The method allows simultaneous extraction of the pharmaceuticals compounds by solid-phase extraction (SPE) using the Waters Oasis HLB at pH 7. The analytes were then identified and quantitatively determined by liquid chromatography–tandem mass spectrometry (LC–MS–MS) using multiple reaction monitoring (MRM). Recoveries of the pharmaceuticals were higher than 75%, with the exception of ranitidine (45%) and the overall variability of the method was below 9%. The instrumental detection limit (IDL) varied between 2 and 31 pg injected, the method detection limit (LOD) was between 7 and 47 ng/L in spiked hospital effluent. The precision of the method, calculated as relative standard deviation (RSD), ranged from 0.3 to 4.9%. A detail study off matrix effect is included in this work, regarding to signal suppression in these effluent wastewaters from a hospital complex samples. The developed analytical method was applied for preliminary data results in effluent wastewaters from a hospital.

Keywords: Liquid chromatography–tandem mass spectrometry; Pharmaceuticals; Hospital wastewaters

Article Outline

1. Introduction
2. Experimental
2.1. Chemicals and materials
2.2. Sampling and sample preparation
2.3. LC–ESI–tandem MS analysis
2.4. Validation of the analytical procedure
3. Results and discussion
3.1. SPE
3.2. Matrix effects
3.3. LC–ESI–tandem MS analysis
3.4. Validation of the analytical method
3.5. Application of the method
4. Conclusions
Acknowledgements
References




Journal of Chromatography A
Volume 1114, Issue 2, 12 May 2006, Pages 224-233
ExTech 2005 - 7th International Symposium on Advances in Extraction Technologies
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.